Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 바이오시밀러

Anti-Human IL-17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO) (HS856106)

Anti-Human IL-17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO)
Anti-Human IL-17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO)
Anti-Human IL-17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO)
Anti-Human IL-17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO)
가격(USD):
사양:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호HS856106
설명
Research Grade Tibulizumab (HS856106) is a humanized monoclonal antibody detecting CTLA-8 in ELISA, Bioactivity: FACS, Functional assay, Research in vivo. Suitable for Human.
Highlights
  • ●Multi-Application — Validated across multiple applications.
종 반응성Human
응용 분야ELISA, Bioactivity: FCM, Functional assay, Research in vivo
숙주 종Human
클론성Monoclonal
이소타입IgG4-kappa-[scFv]2
타겟 CTLA-8, CTLA8, Cytotoxic T-lymphocyte-associated antigen 8, IL-17, IL-17A, IL17, IL17A, Interleukin-17A, B lymphocyte stimulator, B-cell-activating factor, BAFF, BLYS, BLyS, CD257, Dendritic cell-derived TNF-like molecule, TALL-1, TALL1, TNF- and APOL-related leukocyte expressed ligand 1, TNFSF13B, TNFSF20, Tumor necrosis factor ligand superfamily member 13B, Tumor necrosis factor ligand superfamily member 13b, membrane form, Tumor necrosis factor ligand superfamily member 13b, soluble form, ZTNF4
내독소 수준 < 10 EU/mg
순도 >95% as determined by SDS-PAGE.
정제 Protein A/G purified from cell culture supernatant.
등록번호 Q16552 & Q9Y275
형태 Liquid
저장 완충액 0.01M PBS pH 7.4.

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
대체 이름Bispecific, LY 3090106, LY-3090106, LY3090106, 1849636-24-3
배경Tibulizumab (LY-3090106) is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
참고사항 For research use only. Not suitable for clinical or therapeutic use.
이미지
  • Anti-Human IL-17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Tibulizumab.

  • Anti-Human IL-17A & TNFSF13B Bispecific Reference Antibody (Tibulizumab, RUO)

    Bioactivity

    Detects Human IL17A in direct ELISAs.

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록